Interv Akut Kardiol. 2021;20(2):106-110 | DOI: 10.36290/kar.2020.048

Pětileté výsledky po STEMI v éře primární PCI

Viktor Klančík, Viktor Kočka
Department of Cardiology, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic

Tento přehledový článek shrnuje informace dostupné z dlouhodobého sledování pacientů po infarktu myokardu s elevacemi ST úseku (STEMI) v éře primární perkutánní koronární intervence (p-PCI). Jeho hlavním cílem je poskytnout přehled o dlouhodobé celkové mortalitě, kardiální mortalitě a závažných nežádoucích kardiovaskulárních příhodách (MACE). Vyhledali jsme a analyzovali studie s pětiletým a delším obdobím sledování publikované od ledna 2001 do prosince 2019. Do přehledu jsme zařadili pouze studie týkající se p-PCI. Celková mortalita v pěti letech sledování byla 9,3-23,3 % a roční celková mortalita se v letech, které následovaly po uplynutí prvního roku po STEMI, pohybovala okolo 2 %. Kardiální mortalita v pěti letech sledování byla 4,7-16,0 % a roční kardiální mortalita v letech, které následovaly po uplynutí prvního roku po STEMI, byla přibližně 1,1-1,5 %. Kumulativní incidence reinfarktu v pěti letech sledování byla 5,0-18,0 %, srdečního selhání vyžadujícího hospitalizaci 4,0-18,5 %, další revaskularizace 19,0-37,1 % a cévní mozkové příhody 2,6-8,0 %. Kumulativní incidence trombózy ve stentu byla 2,6 %. Kumulativní incidence restenózy byla 7,8 %. Výsledky výše zmíněných studií svědčí o vysokém procentu kardiovaskulárních úmrtí a MACE během dlouhodobého sledování. Vzhledem k těmto skutečnostem vyvstávají otázky ohledně způsobu snížení výskytu MACE a možnosti rutinního využití zobrazování koronárních tepen v období sledování.

Keywords: STEMI, primární PCI, dlouhodobý, sledování.

Received: November 30, 2020; Revised: November 30, 2020; Accepted: November 30, 2020; Prepublished online: December 1, 2020; Published: July 9, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Klančík V, Kočka V. Pětileté výsledky po STEMI v éře primární PCI. Interv Akut Kardiol. 2021;20(2):106-110. doi: 10.36290/kar.2020.048.
Download citation

References

  1. Ibanez B, James S, Agewall S, et al. ESC Scientific Document Group, 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). European Heart Journal 2018; 39(2): 119-177. Go to original source... Go to PubMed...
  2. WHO, 17 May 2017, Cardiovascular diseases (CVDs), retrieved from: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds).
  3. Tousek P, et al. The incidence and outcomes of acute coronary syndromes in a central European country: Results of the CZECH-2 registry. International Journal of Cardiology, 173(2): 204-208.
  4. Jayaraj JC, Davatyan K, Subramanian SS, Priya J. (November 5th 2018). Epidemiology of Myocardial Infarction, Myocardial Infarction, Burak Pamukçu, Intech Open.
  5. Chua SK, Shyu KG, Hung HF, et al. Gender and Age Differences in Short - and Long-Term Outcomes Following Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction. Acta Cardiol Sin 2014; 30(4): 274-283.
  6. Agarwal S, Parashar A, Garg A, et al. Length of stay and long-term mortality following ST elevation myocardial infarction. CatheterCardiovascInterv 2015; 86(Suppl 1): S1-S7. Go to original source... Go to PubMed...
  7. Parodi G, Memisha G, Valenti R, et al. Five year outcome after primary coronary intervention for acute ST elevation myocardial infarction: results from a single centre experience. Heart 2005; 91(12): 1541-1544. Go to original source... Go to PubMed...
  8. Wang F, Gulati R, Lennon RJ, et al. Cancer History Portends Worse Acute and Long-term Noncardiac (but Not Cardiac) Mortality After Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction. Mayo Clin Proc 2016; 91(12): 1680-1692. Go to original source... Go to PubMed...
  9. Fokkema ML, James SK, Albertsson P, et al. Outcome after percutaneous coronary intervention for different indications: long-term results from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). Euro Intervention 2016; 12(3): 303-311. Go to original source... Go to PubMed...
  10. Pedersen F, Butrymovich V, Kelbæk H, et al. Short - and long-term cause of death in patients treated with primary PCI for STEMI. J AmCollCardiol 2014; 64(20): 2101-2108. Go to original source... Go to PubMed...
  11. Yamashita Y, Shiomi H, Morimoto T, et al. Cardiac and Noncardiac Causes of Long-Term Mortality in ST-Segment-Elevation Acute Myocardial Infarction Patients Who Underwent Primary Percutaneous Coronary Intervention. CircCardiovascQualOutcomes 2017; 10(1): e002790. Go to original source... Go to PubMed...
  12. Kapadia S. 26 March 2016, Heart attack patients getting younger, more obese, retrieved from: https://www.acc.org/about-acc/press-releases/2016/03/25/10/00/heart-attack-patients-getting-younger-more-obese.
  13. Kala P, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: Summary of the document prepared by the Czech Society of Cardiology Cor et Vasa 2017; 59: e613-e644. Go to original source...
  14. Widimsky P, Bilkova D, Penicka M, et al. Long-term outcomes of patients with acute myocardial infarction presenting to hospitals without catheterization laboratory and randomized to immediate thrombolysis or interhospital transport for primary percutaneous coronary intervention. Five years' follow-up of the PRAGUE-2 Trial. Eur Heart J 2007; 28(6): 679-684. Go to original source... Go to PubMed...
  15. Kozieradzka A, Kamiński KA, Maciorkowska D, et al. GRACE. TIMI, Zwolle and CADILLAC risk scores--do they predict 5-year outcomes after ST-elevation myocardial infarction treated invasively? Int J Cardiol. 2011; 148(1): 70-75. Go to original source... Go to PubMed...
  16. Doost Hosseiny A, Moloi S, Chandrasekhar J, et al. Mortality pattern and cause of death in a long-term follow-up of patients with STEMI treated with primary PCI. Open Heart 2016; 3(1): e000405. Published 2016 Apr 15. Go to original source... Go to PubMed...
  17. Cui K, Lyu S, Song X, et al. Long-Term Safety and Efficacy of Staged Percutaneous Coronary Intervention for Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Disease. Am J Cardiol 2019; 124(3): 334-342. Go to original source... Go to PubMed...




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.